Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

FLAG Therapeutics

FLAG Therapeutics
2013 FOUNDED
PRIVATE STATUS
Angel LATEST DEAL TYPE
$72.5K LATEST DEAL AMOUNT
1 INVESTORS
Description

Operator of an oncology company intended to develop a dual-acting small molecule for the treatment of Glioblastoma. The company's therapies are based on two investigational product platforms--the Anti-angiogenic/Anti-tubulin (AA/AT) platform and Folate-target Anti-cancer (FTAC) platform that include multiple water-soluble small molecule compounds, enabling doctors to treat multiple cancer types including brain, lung, ovarian and pancreatic.

Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • 9168 Wooden Road
  • Raleigh, NC 27617
  • United States

+1 (919) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore FLAG Therapeutics’s full profile, request a free trial.

FLAG Therapeutics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Angel (individual) 01-Jul-2019 $72.5K 00.000 Completed Generating Revenue
4. Angel (individual) 09-Jan-2019 00.00 00.000 Completed Startup
3. Grant 01-Jan-2017 00.00 0000 Completed Startup
2. Debt - General 06-Mar-2015 $250K $50K Completed Startup
1. Debt - General 20-Mar-2014 $50K $50K Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

FLAG Therapeutics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
U.S. Department of Health and Human Services Government 000 0000 000000 0

FLAG Therapeutics Executive Team (2)

Name Title Board
Seat
Contact
Info
Frank Sorgi Ph.D Founder, President & Chief Executive Officer

1 Former Executive

You’re viewing 1 of 2 executives. Get the full list »

FLAG Therapeutics Board Members (1)

Name Representing Role Since Contact
Info
Frank Sorgi Ph.D FLAG Therapeutics Founder, President & Chief Executive Officer 000 0000